Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sutton, S W
Right arrow Articles by Loggie, B W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutton, S W
Right arrow Articles by Loggie, B W
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MITOMYCIN C
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Intraoperative modality of treatment for peritoneal carcinomatosis: use of hyperthermic interperitoneal chemoperfusion

S W Sutton

Baylor University Medical Center, Dallas, Texas, USA, Zale Lipshy University Hospital, Dallas, Texas, USA

L W Yancey

Baylor University Medical Center, Dallas, Texas, USA, Zale Lipshy University Hospital, Dallas, Texas, USA

V A Chase

Baylor University Medical Center, Dallas, Texas, USA, Zale Lipshy University Hospital, Dallas, Texas, USA

E K Hunley

Baylor University Medical Center, Dallas, Texas, USA, Zale Lipshy University Hospital, Dallas, Texas, USA

T M McCarty

Department of Surgery, Baylor University Medical Center, Dallas, Texas, USA

J A Kuhn

Department of Surgery, Baylor University Medical Center, Dallas, Texas, USA

B W Loggie

Department of Surgery, Zale Lipshy University Hospital, Dallas, Texas, USA

The use of hyperthermia as an adjunct to chemotherapy in the treatment of peritoneal carcinomatosis is a promising technique for patients who otherwise have a poor prognosis for survival. We, herein, report an overview and description of our technique for the safe conduct of this treatment. Included in these data are a total of 71 patients who underwent an intraoperative treatment with Mitomycin C at temperatures of 41-42°C for a 90- to 120-min time period. The treatment protocol, perfusion system description, technical considerations, and potential complications are also included. The prognosis for intraabdominal carcinomatosis is poor with conventional treatments and modalities. We believe that the use of this technique offers a very positive clinical alternative for patients undergoing treatment for laparoscopic palliation of malignant ascites and/or surgical debulking for intraoperative treatment and prevention of metastasis.

Perfusion, Vol. 17, No. 6, 441-446 (2002)
DOI: 10.1191/0267659102pf607oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?